Affiliations: [a] College of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Wuhan, Hubei, China | [b] Department of Respiratory Medicine, Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang Institute of Traditional Chinese Medicine, Xiangyang, Hubei, China
Correspondence:
[*]
Corresponding author: Xing Cai, Department of Respiratory Medicine, Xiangyang Hospital of Traditional Chinese Medicine, Xiangyang Institute of Traditional Chinese Medicine, Xiangyang, Hubei 441000, China. E-mail: [email protected].
Note: [1] WanZhao Zuo, Jing Li and MingYan Zuo contributed equally to this work.
Abstract: BACKGROUND: It is difficult to differentiate between chronic obstructive pulmonary disease (COPD)-peripheral bronchogenic carcinoma (COPD-PBC) and inflammatory masses. OBJECTIVE: This study aims to predict COPD-PBC based on clinical data and preoperative Habitat-based enhanced CT radiomics (HECT radiomics) modeling. METHODS: A retrospective analysis was conducted on clinical imaging data of 232 cases of postoperative pathological confirmed PBC or inflammatory masses. The PBC group consisted of 82 cases, while the non-PBC group consisted of 150 cases. A training set and a testing set were established using a 7:3 ratio and a time cutoff point. In the training set, multiple models were established using clinical data and radiomics texture changes within different enhanced areas of the CT mass (HECT radiomics). The AUC values of each model were compared using Delong’s test, and the clinical net benefit of the models was tested using decision curve analysis (DCA). The models were then externally validated in the testing set, and a nomogram of predicting COPD-PBC was created. RESULTS: Univariate analysis confirmed that female gender, tumor morphology, CEA, Cyfra21-1, CT enhancement pattern, and Habitat-Radscore B/C were predictive factors for COPD-PBC (P< 0.05). The combination model based on these factors had significantly higher predictive performance [AUC: 0.894, 95% CI (0.836–0.936)] than the clinical data model [AUC: 0.758, 95% CI (0.685–0.822)] and radiomics model [AUC: 0.828, 95% CI (0.761–0.882)]. DCA also confirmed the higher clinical net benefit of the combination model, which was validated in the testing set. The nomogram developed based on the combination model helped predict COPD-PBC. CONCLUSION: The combination model based on clinical data and Habitat-based enhanced CT radiomics can help differentiate COPD-PBC, providing a new non-invasive and efficient method for its diagnosis, treatment, and clinical decision-making.
Keywords: Nomograms, retrospective studies, antigen CYFRA21.1, area under curve, radiomics, tomography, X-ray computed, clinical decision-making, pulmonary disease, chronic obstructive
